You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tuberous sclerosis complex 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )

Completed
  • Facial Angiofibroma
  • Tuberous Sclerosis
  • Phoenix, Arizona
  • +16 more
Jul 26, 2022

Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

Recruiting
  • Angiofibroma of Face
  • Tuberous Sclerosis
  • Sirolimus 0.2%
  • +2 more
  • Phoenix, Arizona
  • +7 more
Feb 2, 2022

Tuberous Sclerosis Trial in United States (Ganaxolone)

Completed
  • Tuberous Sclerosis
  • Los Angeles, California
  • +6 more
Oct 27, 2022

Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))

Recruiting
  • Tuberous Sclerosis Complex
  • Acceptance and Commitment Therapy (ACT)
  • Bristol, United Kingdom
    University Hospitals Bristol and Weston NHS Trust
May 10, 2023

Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

Active, not recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • TAVT-18 (sirolimus)
  • Cincinnati, Ohio
    Cincinnati Children's Hospital
Jan 10, 2022

Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

Recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • Birmingham, Alabama
  • +7 more
Sep 2, 2022

TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)

Recruiting
  • TSC
  • Behavioral Symptoms
  • Behavioral Intervention in a small group platform
  • Carrboro, North Carolina
  • +1 more
Oct 23, 2023

Studies in Patients With Tuberous Sclerosis Complex

Recruiting
  • Tuberous Sclerosis Complex
    • Phoenix, Arizona
      Translational Genomics Research Institute (TGen)
    Oct 18, 2022

    Renal Angiomyolipoma Trial (Everolimus)

    Not yet recruiting
    • Renal Angiomyolipoma
    • (no location specified)
    Aug 15, 2022

    Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2022

    Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

    Recruiting
    • Tuberous Sclerosis Complex
    • NPC-12Y gel
    • NPC-12Y placebo gel
    • Toyoake, Aichi, Japan
    • +4 more
    Aug 8, 2022

    Tuberous Sclerosis Complex, Seizures Trial in Boston (GWP42003-P)

    Completed
    Has Results
    • Tuberous Sclerosis Complex
    • Seizures
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 12, 2022

    Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution

    Not yet recruiting
    • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
    • Cannabidiol Oral Solution [Epidiolex]
    • Los Angeles, California
    • +6 more
    May 9, 2023

    Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

    Recruiting
    • Tuberous Sclerosis Complex
    • Basimglurant with crossover to Placebo
    • Placebo with crossover to Basimglurant
    • Phoenix, Arizona
    • +47 more
    Jan 3, 2023

    Tuberous Sclerosis Complex Trial in Lodz, Warsaw (Rapamycin, Placebo)

    Not yet recruiting
    • Tuberous Sclerosis Complex
    • Rapamycin
    • Placebo
    • Lodz, Poland
    • +1 more
    Sep 6, 2022

    Tuberous Sclerosis Complex Trial in United States (Vigabatrin, Placebo)

    Active, not recruiting
    • Tuberous Sclerosis Complex
    • Birmingham, Alabama
    • +12 more
    May 4, 2022

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

      Active, not recruiting
      • Hypomelanotic Macules
      • +8 more
        • Tirana, Albania
        • +7 more
        Mar 23, 2022

        Seizure in Participants With Tuberous Sclerosis Complex Trial in United States (GWP42003-P, SOC)

        Recruiting
        • Seizure in Participants With Tuberous Sclerosis Complex
        • Little Rock, Arkansas
        • +3 more
        Jul 6, 2022

        Lymphangioleiomyomatosis, a Study on Cathepsin K

        Recruiting
        • Lymphangioleiomyomatosis
        • Tuberous Sclerosis Complex
        • 24h urine
        • urine sample
        • Tours, France
          University hospital
        Jul 18, 2022

        Renal Angiomyolipoma Trial in China (Everolimus)

        Completed
        Has Results
        • Renal Angiomyolipoma
        • Wuhan, Hubei, China
        • +4 more
        Sep 3, 2021

        Tuberous Sclerosis Complex, Seizures Trial in Worldwide (GWP42003-P, Placebo)

        Completed
        Has Results
        • Tuberous Sclerosis Complex
        • Seizures
        • Birmingham, Alabama
        • +43 more
        Sep 22, 2022

        Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

        Enrolling by invitation
        • Tuberous Sclerosis Complex
        • Phoenix, Arizona
        • +13 more
        Jan 24, 2023

        Autism Spectrum Disorder and Intellectual Disability

        Recruiting
        • Tuberous Sclerosis
        • +2 more
          • Birmingham, Alabama
          • +5 more
          Jul 29, 2021

          Resective Epilepsy Surgery for TRE

          Recruiting
          • Tuberous Sclerosis Complex
          • Epilepsy
            • Beijing, Beijing, China
              Beijing Children's Hospital
            Mar 6, 2022